Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Ian Read, CEO of New York City-based Pfizer, recently shared his thoughts on high drug prices, the Food and Drug Administration and President Donald Trump's administration in an interview with Here & Now.
Vice President Mike Pence on Tuesday met with families advocating for "right to try" legislation, which would make it easier for terminally ill patients to gain access to experimental medications not approved by the Food and Drug Administration, reports The…
While Sens. Bernie Sanders, I-Vt., and Ted Cruz, R-Texas, didn't agree on much during Tuesday night's ACA debate, the two did find some common ground in one area: high drug costs.
Global Healthcare Exchange released its annual list of the 50 best healthcare supply chains in North America.
Acquisition activity among pharmaceutical companies is expected to continue in 2017 because the key drivers of mergers and acquisitions — slowing revenue growth, pricing pressure, numerous targets with attractive pipeline assets, low financial leverage of acquirers and low-cost financing —…
When planning out delivery routes, United Postal Service follows one simple route: Don't turn left across traffic, reports Big Think.
The Food and Drug Administration gave market clearance for the Seeker System, a screening test designed to detect four metabolic disorders in newborns.
Erez Vigodman stepped down from his role as president and CEO of Teva Pharmaceuticals, reports the Philadelphia Business Journal.
A proposal from the Food and Drug Administration to give biologic drugs and their biosimilar copies more distinct names has faced criticism from drugmakers, organizations and other government bodies, reports The Hill.
Canonsburg, Pa.-based Mylan will pay $96.5 million to settle a class-action lawsuit alleging it entered a "pay-to-delay" deal with the drugmaker Cephalon, reports Bloomberg.